Abstract:Retinal prosthesis systems have undergone significant advances in the past quarter century, resulting in the development of several different novel surgical and engineering approaches. Encouraging results have demonstrated partial visual restoration, with improvement in both coarse objective function and performance of everyday tasks. To date, four systems have received marketing approval for use in Europe or the United States, with numerous others undergoing preclinical and clinical evaluation, reflecting the… Show more
“…The technology of retinal prosthesis has developed gradually, allowing chip implants to electrically stimulate normal neurons to transmit signals. However, many problems still exist, including problems with the design of optical wireless transmission channels, signal resolution processing, and solar cell miniaturization [28][29][30][31]. On the other hand, there is a lack of research on the self-repair and regeneration of RGCs on these chips under electrical stimulation [32].…”
Section: Age-related Macular Degeneration (Amd) and Common Treatment mentioning
Retinal prosthesis has recently emerged as a treatment strategy for retinopathies, providing excellent assistance in the treatment of age-related macular degeneration (AMD) and retinitis pigmentosa. The potential application of graphene oxide (GO), a highly biocompatible nanomaterial with superior physicochemical properties, in the fabrication of electrodes for retinal prosthesis, is reviewed in this article. This review integrates insights from biological medicine and nanotechnology, with electronic and electrical engineering technological breakthroughs, and aims to highlight innovative objectives in developing biomedical applications of retinal prosthesis.
“…The technology of retinal prosthesis has developed gradually, allowing chip implants to electrically stimulate normal neurons to transmit signals. However, many problems still exist, including problems with the design of optical wireless transmission channels, signal resolution processing, and solar cell miniaturization [28][29][30][31]. On the other hand, there is a lack of research on the self-repair and regeneration of RGCs on these chips under electrical stimulation [32].…”
Section: Age-related Macular Degeneration (Amd) and Common Treatment mentioning
Retinal prosthesis has recently emerged as a treatment strategy for retinopathies, providing excellent assistance in the treatment of age-related macular degeneration (AMD) and retinitis pigmentosa. The potential application of graphene oxide (GO), a highly biocompatible nanomaterial with superior physicochemical properties, in the fabrication of electrodes for retinal prosthesis, is reviewed in this article. This review integrates insights from biological medicine and nanotechnology, with electronic and electrical engineering technological breakthroughs, and aims to highlight innovative objectives in developing biomedical applications of retinal prosthesis.
“…Although this does not give a high-quality image, it does allow a blind person sufficient image quality to function and navigate around objects. This work has shown the feasibility of the approach, and work is continuing to improve the image quality [ 76 , 77 ], including increasing the area of the electrode array and increasing the density of electrodes [ 78 , 79 ]. Another approach is to implant arrays of the probe directly into the optical cortex at the back of the brain [ 80 ].…”
In-vivo sensors yield valuable medical information by measuring directly on the living tissue of a patient. These devices can be surface or implant devices. Electrical activity in the body, from organs or muscles can be measured using surface electrodes. For short term internal devices, catheters are used. These include cardiac catheter (in blood vessels) and bladder catheters. Due to the size and shape of the catheters, silicon devices provided an excellent solution for sensors. Since many cardiac catheters are disposable, the high volume has led to lower prices of the silicon sensors. Many catheters use a single sensor, but silicon offers the opportunity to have multi sensors in a single catheter, while maintaining small size. The cardiac catheter is usually inserted for a maximum of 72 h. Some devices may be used for a short-to-medium period to monitor parameters after an operation or injury (1–4 weeks). Increasingly, sensing, and actuating, devices are being applied to longer term implants for monitoring a range of parameters for chronic conditions. Devices for longer term implantation presented additional challenges due to the harshness of the environment and the stricter regulations for biocompatibility and safety. This paper will examine the three main areas of application for in-vivo devices: surface devices and short/medium-term and long-term implants. The issues of biocompatibility and safety will be discussed.
“…Recently, visual prosthetics was implanted in humans with retinitis pigmentosa (RP) and choroideremia, although there was still a limit to visual improvement and safety 4,5 . Although restoration of visual field and visual acuity, and improvement in activities of daily life could be obtained by the implantation of visual prosthetics in advanced stage of retinal disorders, resolution of visual signal was still low to distinguish objects 6,7 . Furthermore, the cost of visual prosthetics is very expensive 8 and surgery of visual prosthetics implantation is difficult and could cause complication such as retinal detachment and dislocation of device 7,9 .…”
mentioning
confidence: 99%
“…Although restoration of visual field and visual acuity, and improvement in activities of daily life could be obtained by the implantation of visual prosthetics in advanced stage of retinal disorders, resolution of visual signal was still low to distinguish objects 6,7 . Furthermore, the cost of visual prosthetics is very expensive 8 and surgery of visual prosthetics implantation is difficult and could cause complication such as retinal detachment and dislocation of device 7,9 . RP is one of inherited retinal dystrophies and one of the causes of irreversible vision loss.…”
We developed and characterized a canine model of outer retinal degeneration induced by sodium iodate (SI) intravitreal injection after vitrectomy. In the preliminary study, we repeatedly injected SI intravitreally into the eyes of three canines to develop outer retinal degeneration two weeks after vitrectomy. Based on the preliminary study, a single dose of either 1.2 mg or 1.0 mg SI/0.05 mL was also injected (1.2 mg in n = 5 canines, 1.0 mg in n = 2 canines). Spectral domain-optical coherence tomography (OCT), electroretinography (ERG), and histological examinations were performed at baseline and following intravitreal injection. In the preliminary study, after a 0.5-mg SI injection and a 1.0-mg SI injection and after two 0.8-mg SI injections, retinal degeneration with retinal thinning was observed on OCT imaging. In the second study, after a single 1.0-or 1.2-mg SI injection, outer retinal degeneration was induced. All eyes showed diffuse outer retinal degeneration on OCT and a loss of both cone and rod responses in ERG. Histological examination also showed the loss of outer retinal layer. Intravitreally injected SI (1.0-1.2 mg) in a vitrectomized canine model induced outer retinal degeneration effectively, and could be evaluated through in vivo ophthalmic examination.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.